Overexpression of interferon regulatory factor 1 enhances chemosensitivity to 5-fluorouracil in gastric cancer cells

Journal of Cancer Research and Therapeutics

Volumn 8, Issue 1, 2012, Pages 57-61

  Gao, Jinbo ^a   Tian, Yuan ^a   Zhang, Jinghui ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; chemosensitivity; gastric cancer; interferon regulatory factor 1

Indexed keywords

FLUOROURACIL; INTERFERON REGULATORY FACTOR 1; TETRACYCLINE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FLUOROURACIL; GENE EXPRESSION; HUMANS; INTERFERON REGULATORY FACTOR-1; POLY(ADP-RIBOSE) POLYMERASES; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84860485587     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.95175     Document Type: Article

References (25)

1. Bayle P, Levin B. World cancer report 2008. Lyno:IARC; 2008.
2. Longley DB, Johnston PG. Molecular mechanism of drug resistance. J Pathol 2005;205:275-92.
3. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002;108:153-64. (Pubitemid 34161136)
4. Kröger A, Köster M, Schroeder K, Hauser H, Mueller PP. Activities of IRF-1. J Interferon Cytokine Res 2002;22:5-14.
5. Savitsky D, Tamura T, Yanai H, Taniguchi T. Regulation of immunity and oncogenesis by the transcription factor family. Cancer Immunol Immunother 2010;59:489-510.
6. Stang MT, Armstrong MJ, Watson GA, Sung KY, Liu Y, Ren B, et al. Interferon regulatory factor-1-induced apoptosis mediated by ligandindependent fas-associated death domain pathway in breast cancer cells. Oncogene 2007;26:6420-30. (Pubitemid 47494223)
7. Papageorgiou A, Dinney CP, McConkey DJ. Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol Ther 2007;6:872-9. (Pubitemid 351574976)
8. Watson GA, Queiroz de Oliveira PE, Stang MT, Armstrong MJ, Gooding WE, Kuan SF, et al. Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma. Neoplasia 2006;8:31-7.
9. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003;3:17-22. (Pubitemid 37443888)
10. Rodriquez-Nieto S, Zhivotovsky B. Role of alterations in the apoptotic machinery in sensitivity of cancer cells to treatment. Curr Pharm Des 2006;12:4411-25. (Pubitemid 44835154)
11. Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 1994;77:829-39. (Pubitemid 24187681)
12. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, et al. An IRF-1 dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 1995;376:596-9.
13. Kim EJ, Lee JM, Namkoong SE, Um SJ, Park JS. Interferon regulatory factor-1 mediates interferon-gamma-induced apotosis in ovarian carcinoma cells. J Cell Biochem 2002;85:369-80.
14. Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J 2004;23:3051-60. (Pubitemid 39093599)
15. Suk K, Chang I, Kim YH, Kim S, Kim JY, Kim H, et al. Interferon gamma (IFNgamma) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. J Biol Chem 2001,276:13153-9.
16. Tamura G, Ogasawara S, Nishizuka S, Sakata K, Maesawa C, Suzuki Y, et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res 1996;56:612-5. (Pubitemid 26043662)
17. Nozawa H, Oda E, Ueda S, Tamura G, Maesawa C, Muto T, et al. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer. Int J Cancer 1998;77:522-7. (Pubitemid 28340897)
18. Tzoanopoulos D, Speletas M, Arvanitidis K, Veiopoulou C, Kyriaki S, Thyphronitis G, et al. Low expression of interferon regulatory factor-1 and identification of novel exons skipping in patients with chronic myeloid leukaemia. Br J Haematol 2002;119:46-53. (Pubitemid 35176497)
19. Park J, Kim K, Lee EJ, Seo T, Jang IS, Choi JS, et al. Elevated level of SUMOylated IRF-1 in tumor cells interferes with IRF-1-mediated apoptosis. Proc Natl Acad Sci U S A 2007;104:17028-33. (Pubitemid 350210985)
20. Jin Z, EI-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005;4:139-63. (Pubitemid 41351311)
21. Upreti M, Koonce NA, Hennings L, Chambers TC, Griffin RJ. Pegylated IFN-α sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling. Cell Death Dis 2010;1:e67.
22. Sun QH, Peng JP, Xia HF. IFNgamma pretreatment sensitizes human choriocarcinoma cells to etoposide-induced apoptosis. Mol Hum Reprod 2006;12:99-105.
23. Bowie ML, Dietze EC, Delrow J, Bean GR, Troch MM, Marjoram RJ, et al. Interferon-regulatory factor-1 is critical for tamoxifenmediated apoptosis in human mammary epithelial cells. Oncogene 2004;23:8743-55. (Pubitemid 39593289)
24. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodríguez A, Ortiz-Ferrón G, Redondo JM, López-Rivas A. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 2004;279:19712-20. (Pubitemid 38623409)
25. Chow WA, Fang JJ, Yee JK. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. J Immunol 2000;164:3512-8. (Pubitemid 30169802)